Henrik Sundin

Director/Board Member at HAMLET PHARMA AB (PUBL)

Finance

Health Technology

Commercial Services

Profile

Henrik Sundin is the founder of Finserve Nordic AB, founded in 2006, holding the title of Partner.
Mr. Sundin is currently Director at Infra Group Nordic Consulting AB since 2019 and Director at Hamlet BioPharma AB since 2025.
Mr. Sundin was Chief Executive Officer at Movestic Fonder AB from 2010 to 2016.

Henrik Sundin active positions

Companies	Position	Start
HAMLET PHARMA AB (PUBL)	Director/Board Member	04/12/2025
Finserve Nordic AB Finserve Nordic AB Investment ManagersFinance Provides investment advice	Founder	01/11/2006
Infra Group Nordic Consulting AB Infra Group Nordic Consulting AB Miscellaneous Commercial ServicesCommercial Services Provides infrastructure services	Director/Board Member	01/12/2019

All active positions of Henrik Sundin

Former positions of Henrik Sundin

Companies	Position	End
Movestic Kapitalförvaltning AB Movestic Kapitalförvaltning AB Investment ManagersFinance Movestic Fonder employs active and passive strategies to manage their funds, aiming to achieve significant, stable returns by diversifying risk and continuously adapting their funds. Their geographic focus is on Nordic countries. The firm invests in equity and fixed income. They may also invest directly in certificates and may use derivatives for efficient portfolio management and/or hedging purposes.	Chief Executive Officer	01/08/2016

See the detail of Henrik Sundin's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Henrik Sundin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Finserve Nordic AB Finserve Nordic AB Investment ManagersFinance Provides investment advice	Finance
Movestic Kapitalförvaltning AB Movestic Kapitalförvaltning AB Investment ManagersFinance Movestic Fonder employs active and passive strategies to manage their funds, aiming to achieve significant, stable returns by diversifying risk and continuously adapting their funds. Their geographic focus is on Nordic countries. The firm invests in equity and fixed income. They may also invest directly in certificates and may use derivatives for efficient portfolio management and/or hedging purposes.	Finance
Hamlet BioPharma AB Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients	Health Technology
Infra Group Nordic Consulting AB Infra Group Nordic Consulting AB Miscellaneous Commercial ServicesCommercial Services Provides infrastructure services	Commercial Services